This 2018 review critically examines the use of high-dose intravenous vitamin C (IVC) in cancer therapy, highlighting the lack of standardized clinical protocols and definitive evidence. It addresses key questions regarding IVC's safety, optimal dosing, interaction with conventional treatments, and mechanisms of action, such as pro-oxidant effects leading to hydrogen
